Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07166016 · ClinicalTrials.gov registry record · NA
Treatment Effects on Gait in Hammertoe Patients
A NA study of Hammertoe, sponsored by University of Texas Rio Grande Valley.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT07166016: Recruiting NA study of Hammertoe, sponsored by University of Texas Rio Grande Valley.
NCT07166016 is a NA study of Hammertoe that is actively recruiting participants, run by University of Texas Rio Grande Valley. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07166016, a NA study of Hammertoe, is actively recruiting participants, sponsored by University of Texas Rio Grande Valley.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
This study looks at how hammertoe deformities affect foot pressure distribution and whether proper treatment can improve quality of life.
Conditions Studied
Interventions
- OTHER Conservative
- PROCEDURE Surgical
Study Locations (1)
Texas
- University of Texas Rio Grande Valley - Harlingen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2025-10-01 |
| Est. Completion | 2027-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07166016
The ClinicalTrials.gov registry entry for NCT07166016 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The listed sponsor is University of Texas Rio Grande Valley, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hammertoe appearing as the primary indexed condition, and to 2 interventions - of which Conservative is the first listed.
NCT07166016 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT07166016 about?
NCT07166016 is a clinical study titled "Treatment Effects on Gait in Hammertoe Patients". This study looks at how hammertoe deformities affect foot pressure distribution and whether proper treatment can improve quality of life.
What is the current status of trial NCT07166016?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-10-01. Estimated completion is 2027-12-31.
What conditions does trial NCT07166016 study?
This clinical trial studies the following conditions: Hammertoe.
What interventions are being tested in trial NCT07166016?
The interventions under investigation include: Conservative (OTHER), Surgical (PROCEDURE).
Who is sponsoring clinical trial NCT07166016?
This trial is sponsored by University of Texas Rio Grande Valley, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07166016 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.